Recombinant Human Serum Albumin

Click enlarge Image

Product Detail

Company Info

 

Product Detail

Company Info

 

Healthgen Biotechnology Corp. is a private company, which was founded in 2006. We are focusing on developing, manufacturing and marketing a series of environmental friendly and safe products by using the State-of-the-Art platform called OryzHiExp, which can highly expresse proteins or small peptides in the cereal crops.
Utilizing the OryzHiExp platform, Healthgen Biotechnology maximizes the innovative animal-free product development opportunities for clients and partners. Its cost-effective expression capability made it become a breakthrough expression platform.
Gained a number of patented technologies, Healthgen Biotechnology has achievements in developing and commercializing products, such as: OsrHSA (recombinant human serum albumin), OsrAAT (recombinant α1-anti-trypsin), OsraFGF (recombinant acid fibroblast growth factor), and OsrbFGF (recombinant basic fibroblast growth factor). Meanwhile we are experiencing cooperation with other prospective biotechnology and pharmaceutical companies in expressing their ideal proteins or peptides.
Healthgen Biotechnology‘s Quality Control System has been certified by SGS against the ISO 9001: 2008 requirements, which ensures standardized process as well as qualified products. With the scale production facilities built and managed according to the GMP requirement, all products meet current required standards and can be suitable for the usage as the cell culture media supplements, cosmetic additives, industrial reagents, bio-pharmaceuticals and life science researches. Healthgen Biotechnology is uniquely positioned to become a scientific leader in the biopharmaceutical industry. We are dedicated to developing and producing the safe, cheep, green and sufficient biomedicine.

We have achieved scientific excellence through internal research and development and collaborations with world-renowned biotech and industry leaders. Together we have created a rich product pipeline with innovative products in human therapeutics.

In 2007, Healthgen Biotechnology's scientists developed a breakthrough protein expression technology with unrivaled efficiency. This proprietary technology platform is called OryzExpress. OryzExpress's cost-efficiency and proven commercial scalability make it possible for Healthgen to address unmet and underserved needs in human and animal health by delivering affordable treatments on a global scale.

Healthgen Biotechnology has a number of patented technologies, series of products development and industrialization. Healthgen Biotechnology has successfully made use of the technique to express the recombinant human serum albumin (OsrHSA), recombinant human antitrypsin(rAAT), recombinant insulin-like growth factor(OsrIGF-1), recombinant acid fibroblast growth factor(OsraFGF), recombinant basic fibroblast growth factor(OsrbFGF)and other products.